3rd Annual Protein and Peptide Formulation Strategies for Drug Development and Delivery
Venue: Hilton San Francisco
|Event Date/Time: Mar 29, 2004||End Date/Time: Mar 31, 2004|
Maximize the science that drives formulation, process, delivery, and commercialization.
Key Features of Day One: Workshops
Day one begins with an in-depth pre-conference workshop on Applications for Nanoparticle Design and Microfabrication in Protein and Peptide Delivery. This workshop allows participants to assess where nano and micro technology might fit into their organization. The afternoon workshop addresses Strategies for Understanding and Measuring Immunogenicity of Recombinant Protien Therapeutics presented by Meena Subramanyam, PhD, Director, Clinical Science Technology BIOGEN IDEC and Eric Wakshull, PhD Principal Scientist, Clinical Science and Technology BIOGEN IDEC. This workshop details implementing appropriate assays to determine immunogenicity of protein therapeutics.
Key Features of Day Two
Physical and Chemical Stability
Keynote Presentation: Protein Aggregation in Aqueous Solution: Mechanism, Inhibition and Reversal
John Carpenter, PhD
Associate Professor Pharmaceutics
UNIVERSITY OF COLORADO HEALTH SCIENCES CENTER
Featured Presentation: A Phase Diagram/High Throughput Screening Approach to Protein and Vaccine Formulation
C. Russell Middaugh, PhD
Takeru and Aya Higuchi Distinguished Professor
THE UNIVERSITY OF KANSAS
MEDIMMUNE VACCINES presents formulation to stabilize live vaccines for room temperature storage
MERCK AND CO presents a case study on formulation challenges for protein and peptide stability in solution
Processing of Proteins and Peptides
Featured Presentation: Stabilization of Proteins by Freeze Drying: Stability Prediction by Materials Science
Michael Pikal, PhD
UNIVERSITY OF CONNECTICUT
Attend a series of innovative technology presentations from the leaders in protein and peptide formulation and drug delivery technology.
Key Features of Day Three
Protein and Peptide Delivery
Guy Furness, Editor, DRUG DELIVERY AND COMMERCE, presents drug delivery nanotechnology: finding and understanding the reality behind the hype and skepticism
EMISPHERE TECHNOLOGY, INC addresses oral administration: breakthroughs, challenges, and opportunities
THE JOHNS HOPKINS UNIVERSITY presents targeted delivery using new polymeric carriers
AMGEN identifies delivery strategies for peptides.
PANEL DISCUSSION: Determine appropriate formulation strategies for injectable, intranasal, pulmonary, and oral delivery mechanisms through expert led panel discussion
Former FDA Researcher-Reviewer and current Director of Regulatory for MEDIMMUNE walks through a complete submission process, highlighting lessons learned.
HELLER EHRMAN WHITE AND MCAULIFFE presents strategies to anticipate regulatory change to follow technological advances.
In its third year, IIR’s Protein and Peptides conference presents an opportunity to gain exposure to companies and industry experts leading the pace toward selecting the most appropriate formulation for a protein or peptide drug for efficient, cost effective, patient compliance, and safety. If you are involved in protein or peptide formulation and delivery at a pharmaceutical or biotech company, drug delivery company, academic research institute or CRO you will benefit by attending this industry gathering.